Hepatitis: Hirschfield GM

 Topic:  
Hints · Remembered Topics    
  Start Here  Overview  World Articles  Find Experts  Books & DVDs  Help 
 
Column View Map 5 Articles   Help
A digest of articles written 1999 and later, on the topic "Hepatitis," originating from Planet Earth —» Hirschfield GM.  Display:  All Citations ·  All Abstracts
1 Editorial T regulatory cells and autoimmune liver disease. 2008

Hirschfield GM, Heathcote J. · No affiliation provided · Liver Int. · Pubmed #18251975 No free full text.

This publication has no abstract.

2 Review Managing hepatitis C virus infection. 2009

Nash KL, Bentley I, Hirschfield GM. · Southampton University Hospitals NHS Trust, Southampton. · BMJ. · Pubmed #19561051 No free full text.

This publication has no abstract.

3 Article Fatal reactivation of hepatitis B after chemotherapy for lymphoma. 2008

Dillon R, Hirschfield GM, Allison ME, Rege KP. · Department of Haematology, Hinchingbrooke Hospital, Huntingdon. · BMJ. · Pubmed #18595895 No free full text.

This publication has no abstract.

4 Article New insights into autoimmune liver diseases. 2008

Kumagi T, Alswat K, Hirschfield GM, Heathcote J. · Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. · Hepatol Res. · Pubmed #18462376 No free full text.

Abstract: Autoinflammatory liver disease represents an important aspect of global hepatological practice. The three principal disease divisions recognized are autoimmune hepatitis, primary sclerosing cholangitis and primary biliary cirrhosis. Largely, but not exclusively, these diseases are considered to be autoimmune in origin. Increased recognition of outlier and overlap syndromes, changes in presentation and natural history, as well as the increased awareness of IgG4-associated sclerosing cholangitis, all highlight the limitations of the classic terminology. New insights continue to improve the care given to patients, and have arisen from carefully conducted clinical studies, therapeutic trials, as well as genetic and laboratory investigations. The challenges remain to treat patients before liver injury becomes permanent and to prevent the development of organ failure.

5 Minor Transient development of anti-mitochondrial antibodies accompanies autoimmune hepatitis-sclerosing cholangitis overlap. 2009

Bhat M, Guindi M, Heathcote EJ, Hirschfield GM. · No affiliation provided · Gut. · Pubmed #19091843 No free full text.

This publication has no abstract.